Woman Diagnosed with Blood Cancer During Pregnancy Delivers Healthy Baby Girl at Delhi Hospital
A 32-year-old woman diagnosed with acute myeloid leukemia (AML) during her pregnancy has successfully delivered a healthy baby girl at a Delhi hospital, marking a rare medical achievement. The patient, who was 20 weeks pregnant when diagnosed, underwent intensive chemotherapy while closely monitoring the fetus's health.
The case was managed by a multidisciplinary team at the hospital, including hematologists, obstetricians, and neonatologists. The mother received two cycles of chemotherapy during the second and third trimesters, which effectively controlled the leukemia without harming the baby. At 34 weeks, doctors performed a planned cesarean section, delivering a 2.1 kg baby girl who is currently healthy and thriving.
Challenges in Treating Cancer During Pregnancy
Treating acute myeloid leukemia during pregnancy presents significant challenges. Chemotherapy drugs can potentially harm the developing fetus, especially during the first trimester. However, in this case, the diagnosis was made after the first trimester, allowing for safer treatment options. The medical team used a specialized chemotherapy regimen known to be relatively safe during pregnancy, with careful dose adjustments and fetal monitoring throughout.
The patient experienced common side effects such as nausea and fatigue but responded well to treatment. Regular ultrasounds and fetal heart rate monitoring ensured the baby's well-being. The hospital's neonatal intensive care unit (NICU) was prepared for any complications, but the baby was born without any abnormalities.
Successful Outcome and Future Follow-Up
Both mother and baby are now doing well. The mother continues to receive follow-up care for her leukemia, including potential maintenance therapy or stem cell transplant evaluation. The baby is being monitored for any long-term effects of prenatal chemotherapy exposure, though initial assessments show normal development.
This case highlights the importance of a coordinated, multidisciplinary approach to managing cancer during pregnancy. With advances in medical care, women diagnosed with cancer while pregnant can achieve successful outcomes for both themselves and their babies. The hospital plans to publish the case details in a medical journal to contribute to the growing body of knowledge on this rare condition.
Dr. Ramesh Kumar, the lead hematologist, stated: “This case demonstrates that with careful planning and expert care, it is possible to treat aggressive cancers like AML during pregnancy. The key is early diagnosis, individualized treatment, and close collaboration among specialists.”
The patient expressed gratitude to the medical team, saying she is relieved to hold her healthy baby girl after a challenging journey. She now looks forward to continuing her cancer treatment while enjoying motherhood.
